1. Home
  2. PHVS vs CWH Comparison

PHVS vs CWH Comparison

Compare PHVS & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • CWH
  • Stock Information
  • Founded
  • PHVS 2015
  • CWH 1966
  • Country
  • PHVS Netherlands
  • CWH United States
  • Employees
  • PHVS N/A
  • CWH N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • CWH Retail-Auto Dealers and Gas Stations
  • Sector
  • PHVS Health Care
  • CWH Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • CWH Nasdaq
  • Market Cap
  • PHVS 1.0B
  • CWH 1.4B
  • IPO Year
  • PHVS 2021
  • CWH 2016
  • Fundamental
  • Price
  • PHVS $18.36
  • CWH $22.90
  • Analyst Decision
  • PHVS Strong Buy
  • CWH Strong Buy
  • Analyst Count
  • PHVS 5
  • CWH 8
  • Target Price
  • PHVS $40.60
  • CWH $27.25
  • AVG Volume (30 Days)
  • PHVS 48.5K
  • CWH 1.3M
  • Earning Date
  • PHVS 11-13-2024
  • CWH 02-19-2025
  • Dividend Yield
  • PHVS N/A
  • CWH 2.19%
  • EPS Growth
  • PHVS N/A
  • CWH N/A
  • EPS
  • PHVS N/A
  • CWH N/A
  • Revenue
  • PHVS N/A
  • CWH $6,004,843,000.00
  • Revenue This Year
  • PHVS N/A
  • CWH N/A
  • Revenue Next Year
  • PHVS N/A
  • CWH $7.73
  • P/E Ratio
  • PHVS N/A
  • CWH N/A
  • Revenue Growth
  • PHVS N/A
  • CWH N/A
  • 52 Week Low
  • PHVS $15.21
  • CWH $17.29
  • 52 Week High
  • PHVS $33.00
  • CWH $28.72
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 48.93
  • CWH 56.15
  • Support Level
  • PHVS $15.21
  • CWH $21.96
  • Resistance Level
  • PHVS $19.59
  • CWH $23.75
  • Average True Range (ATR)
  • PHVS 1.39
  • CWH 0.93
  • MACD
  • PHVS -0.02
  • CWH 0.29
  • Stochastic Oscillator
  • PHVS 67.31
  • CWH 76.75

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is retailer of RVs and related products and services. The Company has the two reportable segments: Good Sam Services and Plans segment includes sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories. RV and Outdoor Retail segment includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, sale of outdoor products, equipment, gear and supplies; business to business distribution of RV furniture, etc.

Share on Social Networks: